[go: up one dir, main page]

IT1258781B - Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol - Google Patents

Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol

Info

Publication number
IT1258781B
IT1258781B ITMI920074A ITMI920074A IT1258781B IT 1258781 B IT1258781 B IT 1258781B IT MI920074 A ITMI920074 A IT MI920074A IT MI920074 A ITMI920074 A IT MI920074A IT 1258781 B IT1258781 B IT 1258781B
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
polyvinyl alcohol
composition containing
acetylcistein
ophthalmic pharmaceutical
Prior art date
Application number
ITMI920074A
Other languages
English (en)
Inventor
Federico Stroppolo
Daniele Bonadeo
Annibale Gazzaniga
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of ITMI920074A0 publication Critical patent/ITMI920074A0/it
Priority to ITMI920074A priority Critical patent/IT1258781B/it
Priority to AT93100278T priority patent/ATE239485T1/de
Priority to DE69332939T priority patent/DE69332939T2/de
Priority to AU31136/93A priority patent/AU653091B2/en
Priority to ES93100278T priority patent/ES2197146T3/es
Priority to EP93100278A priority patent/EP0551848B1/en
Priority to CA002087420A priority patent/CA2087420C/en
Priority to JP00615293A priority patent/JP3443128B2/ja
Publication of ITMI920074A1 publication Critical patent/ITMI920074A1/it
Priority to US08/214,232 priority patent/US5510101A/en
Priority to US08/253,587 priority patent/US5488069A/en
Application granted granted Critical
Publication of IT1258781B publication Critical patent/IT1258781B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Viene descritta una composizione farmaceutica oftalmica contenente un'associazione di N-acetilcisteina e di polivinilalcol utile nel trattamento della keratoconjunctivitis sicca.
ITMI920074A 1992-01-16 1992-01-16 Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol IT1258781B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
ITMI920074A IT1258781B (it) 1992-01-16 1992-01-16 Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol
ES93100278T ES2197146T3 (es) 1992-01-16 1993-01-11 Composicion oftalmica que contiene n-acetil-cisteina y alcohol de polivinilo.
DE69332939T DE69332939T2 (de) 1992-01-16 1993-01-11 Ophthalmische pharmazeutische Zubereitung die N-Acetylcystein und Polyvinylalkohol enthält
AU31136/93A AU653091B2 (en) 1992-01-16 1993-01-11 Ophthalmic pharmaceutical composition containing N-acetyl-cysteine and polyvinylalcohol
AT93100278T ATE239485T1 (de) 1992-01-16 1993-01-11 Ophthalmische pharmazeutische zubereitung die n- acetylcystein und polyvinylalkohol enthält
EP93100278A EP0551848B1 (en) 1992-01-16 1993-01-11 Ophthalmic pharmaceutical composition containing N-acetyl-cysteine and polyvinylalcohol
CA002087420A CA2087420C (en) 1992-01-16 1993-01-15 Ophthalmic pharmaceutical composition containing n-acetyl-cisteine and polyvinylalcohol
JP00615293A JP3443128B2 (ja) 1992-01-16 1993-01-18 Ｎ−アセチル−システイン及びポリビニルアルコールを含有する乾性角結膜炎の処置用の組成物
US08/214,232 US5510101A (en) 1992-01-16 1994-03-17 Ophthalmic pharmaceutical composition containing N-acetyl-cysteine and polyvinylalcohol
US08/253,587 US5488069A (en) 1992-01-16 1994-06-03 Ophthalmic pharmaceutical composition containing N-acetyl-cysteine and polyvinylalcohol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI920074A IT1258781B (it) 1992-01-16 1992-01-16 Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol

Publications (3)

Publication Number Publication Date
ITMI920074A0 ITMI920074A0 (it) 1992-01-16
ITMI920074A1 ITMI920074A1 (it) 1993-07-16
IT1258781B true IT1258781B (it) 1996-02-29

Family

ID=11361572

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI920074A IT1258781B (it) 1992-01-16 1992-01-16 Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol

Country Status (9)

Country Link
US (2) US5510101A (it)
EP (1) EP0551848B1 (it)
JP (1) JP3443128B2 (it)
AT (1) ATE239485T1 (it)
AU (1) AU653091B2 (it)
CA (1) CA2087420C (it)
DE (1) DE69332939T2 (it)
ES (1) ES2197146T3 (it)
IT (1) IT1258781B (it)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7330200A (en) * 1999-08-09 2001-05-10 Webb-Waring Institute For Biomedical Research A method for the treatment of ocular oxidative stress
JP5242877B2 (ja) * 2000-04-26 2013-07-24 オレゴン ヘルス アンド サイエンス ユニバーシティー チオールをベースとする化学保護剤の投与
ES2254523T3 (es) * 2000-11-22 2006-06-16 Rxkinetix, Inc. Tratamiento de mucositis.
FR2819186A1 (fr) * 2001-01-10 2002-07-12 L M D Cystine-voie orale-syndrome de l'oeil sec
ITRM20010438A1 (it) * 2001-07-23 2003-01-23 Farmigea Spa Preparato oftalmico a base di n-acetilcisteina per il trattamento della sindrome dell'occhio secco.
GB0123115D0 (en) * 2001-09-26 2001-11-14 Pharma Sol Int Ltd Saline solutions for clinical use
US20050118261A1 (en) * 2003-06-12 2005-06-02 Oien Hal J. Compositions and methods of administering doxepin to mucosal tissue
US20070077303A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for providing oxidatively stable ophthalmic compositions
US7501452B2 (en) * 2005-11-30 2009-03-10 Endo Pharmaceuticals Inc. Treatment of xerostomia
SI3184526T1 (sl) 2005-12-13 2019-03-29 Incyte Holdings Corporation Derivati pirolo(2,3-D)pirimidina kot inhibitorji Janus kinaze
MX2009013402A (es) 2007-06-13 2010-02-24 Incyte Corp Sales de inhibidor de janus cinasa (r)-3-(4-(7h-pirrolo[2,3-d]piri midin-4-il)-1h-pirazol-1-il)-3-ciclopentilpropanitrilo.
CL2009001884A1 (es) * 2008-10-02 2010-05-14 Incyte Holdings Corp Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
WO2010135650A1 (en) * 2009-05-22 2010-11-25 Incyte Corporation N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
WO2010135621A1 (en) 2009-05-22 2010-11-25 Incyte Corporation 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
TW201113285A (en) * 2009-09-01 2011-04-16 Incyte Corp Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
PE20130038A1 (es) 2010-03-10 2013-01-28 Incyte Corp Derivados de piperidin-4-il azetidina como inhibidores de jak1
SG10201503983QA (en) 2010-05-21 2015-06-29 Incyte Corp Topical Formulation for a JAK Inhibitor
BR112013012502A2 (pt) 2010-11-19 2019-03-06 Incyte Corporation pirrolopiridina ciclobutil substituída e derivados de pirrolopirimidina derivativos como inibidores de jak
EP2640725B1 (en) 2010-11-19 2015-01-07 Incyte Corporation Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
EP2721028B1 (en) 2011-06-20 2015-11-04 Incyte Corporation Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
TW201313721A (zh) 2011-08-18 2013-04-01 Incyte Corp 作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
UA111854C2 (uk) 2011-09-07 2016-06-24 Інсайт Холдінгс Корпорейшн Способи і проміжні сполуки для отримання інгібіторів jak
AR091079A1 (es) 2012-05-18 2014-12-30 Incyte Corp Derivados de pirrolopirimidina y pirrolopiridina sustituida con piperidinilciclobutilo como inhibidores de jak
PL2919766T3 (pl) 2012-11-15 2021-10-04 Incyte Holdings Corporation Postacie dawkowania ruksolitynibu o przedłużonym uwalnianiu
EP3489239B1 (en) 2013-03-06 2021-09-15 Incyte Holdings Corporation Processes and intermediates for making a jak inhibitor
LT3030227T (lt) 2013-08-07 2020-06-10 Incyte Corporation Prailginto atpalaidavimo jak1 inhibitoriaus dozavimo formos
AU2015257874B2 (en) 2014-05-07 2019-11-28 Croma-Pharma Gesellschaft M.B.H. Aqueous ophthalmic solution and method for treating dry eye syndrome
US9498467B2 (en) 2014-05-30 2016-11-22 Incyte Corporation Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
ES2796361T3 (es) 2015-10-30 2020-11-26 Croma Pharma Gmbh Uso terapéutico de una solución oftálmica acuosa estéril
RU2018119674A (ru) 2015-10-30 2019-12-02 Крома-Фарма Гезелльшафт М.Б.Х. Применение в терапии стерильного водного офтальмологического раствора
BR112019020444A2 (pt) 2017-03-29 2020-04-28 Azura Ophthalmics Ltd agentes para aumentar a secreção de lipídio da glândula meibomiana
EP3618803A1 (en) 2017-05-03 2020-03-11 Croma-Pharma GmbH Sterile aqueous ophthalmic solution containing n-(n-acetylcysteinyl)-chitosan for treating non-infectious corneal disorders
AR113922A1 (es) 2017-12-08 2020-07-01 Incyte Corp Terapia de combinación de dosis baja para el tratamiento de neoplasias mieloproliferativas
MX2020007973A (es) 2018-01-30 2020-12-07 Incyte Corp Procesos para preparar (1-(3-fluoro-2-(trifluorometil)isonicotinil )piperidin-4-ona).
SI3773593T1 (sl) 2018-03-30 2024-08-30 Incyte Corporation Zdravljenje hidradenitisa suppurative z zaviralci jak
JP2022553868A (ja) * 2019-11-08 2022-12-26 レティナ ファウンデーション オブ ザ サウスウエスト 眼障害を治療するための化合物およびインプラント
US11833155B2 (en) 2020-06-03 2023-12-05 Incyte Corporation Combination therapy for treatment of myeloproliferative neoplasms

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4120949A (en) * 1977-10-05 1978-10-17 Cooper Laboratories, Inc. Ophthalmic solution
US4131651A (en) * 1977-10-25 1978-12-26 Barnes-Hind Pharmaceuticals, Inc. Treatment of dry eye
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
BE901885A (fr) * 1985-03-06 1985-07-01 Bruschettini Srl Composition pharmaceutique sous forme de lotion ophtalmique et son procede de preparation.
US4883658A (en) * 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
IT1249047B (it) * 1991-02-21 1995-02-11 Zambon Spa Composizione farmaceutica per il trattamento della cataratta
NZ242358A (en) * 1991-05-10 1994-03-25 Allergan Inc Use of thiol compounds to inhibit deposits on a contact lens

Also Published As

Publication number Publication date
JPH069383A (ja) 1994-01-18
JP3443128B2 (ja) 2003-09-02
ES2197146T3 (es) 2004-01-01
ITMI920074A1 (it) 1993-07-16
ATE239485T1 (de) 2003-05-15
AU3113693A (en) 1993-07-22
DE69332939T2 (de) 2004-04-01
EP0551848A1 (en) 1993-07-21
US5488069A (en) 1996-01-30
EP0551848B1 (en) 2003-05-07
CA2087420A1 (en) 1993-07-17
US5510101A (en) 1996-04-23
AU653091B2 (en) 1994-09-15
CA2087420C (en) 2004-04-20
ITMI920074A0 (it) 1992-01-16
DE69332939D1 (de) 2003-06-12

Similar Documents

Publication Publication Date Title
IT1258781B (it) Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol
RU95106823A (ru) Сукциноиламиногидроксиэтиламиносульфонамиды, фармацевтическая композиция, способ ингибирования ретровирусной протеазы, способ лечения ретровирусной инфекции способ лечения спида
RU94028653A (ru) Фармацевтический препарат
EP1210941A3 (en) Pharmaceutical compositions containing ritonavir (ABT-538) in combination with indinavir (MK-639) and their use for treating AIDS
ES2191102T3 (es) Heterociclos de peptidilo utiles en el tratamiento de las afecciones relacionadas con la trombina.
ES2100046T3 (es) Composiciones antipireticas y analgesicas que contienen r-ketorolaco opticamente puro.
AR002932A1 (es) Solucion acuosa de interferon
AU6022890A (en) Diarylacetylenes, the preparations and use thereof
RU94040170A (ru) Изохинолины
MX9302927A (es) Nuevos peptidos, la preparacion y utilizacion de los mimos.
ITMI921413A0 (it) Preparazioni farmaceutiche stabili di nicorandil
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
IT1264965B1 (it) Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
ATE81462T1 (de) Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie.
ATE152354T1 (de) Protein c-haltige pharmazeutische präparation als mittel gegen entzündungen
EA199700136A1 (ru) Способы ингибирования экзогенных эстрогенов
EP0350738A3 (de) (S)-Emopamil zur Anwendung bei der Behandlung von Migräne
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
FR2687915B1 (fr) Composition pharmaceutique utilisable comme analgesique contenant l'acide (benzoyl-3 phenyl)-2 propionique-(r).
ATE189395T1 (de) Verwendung von protease nexin-i als mittel gegen entzündungen
IT1276040B1 (it) Uso della benzidamina nel trattamento di stati patologici causati dal tnf
FI870890A0 (fi) Antiglaucomafoereningar.
IT1242475B (it) Agente colinergico, in particolare glicil-p-ammino-piridina-anilide- monoacetato, per il trattamento degli stati di demenza senile.
DE59008693D1 (de) Gewebs-Plasminogen-Aktivator-Derivat.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971209